December 31, 2020 Dear Friends of the EIPM, Welcome to our final quarterly newsletter of the 2020! You signed-up on our website to receive this newsletter, and we hope you enjoy learning more about our researchers and the breakthroughs they are...
Read more
Immunotherapy Extends Survival in Esophageal Cancer December 02, 2020 The immunotherapy drug pembrolizumab, known by its brand name Keytruda, is a safe and effective option for patients with locally advanced and metastatic squamous cell...
Read more
The EIPM External Newsletter below is sent quarterly to people who sign-up on our website. Dear Friends of the EIPM: During these extraordinary times we have continued to create breakthroughs in basic research that will benefit patients with...
Read more